Abiopharma

BioCardia Letter to Stockholders on 2026 Priorities and Strategic Opportunities

Energy Fuels Receives Conditional U.S. Government Support to Accelerate Growth in Rare Earths and Critical Materials

PERMIAN BASIN ROYALTY TRUST ANNOUNCES JUNE CASH DISTRIBUTION, EXCESS COST POSITION ON WADDELL RANCH PROPERTIES, AND SOFTVEST PROPOSAL

Prime Medicine Announces New Zealand Clearance of Clinical Trial Application for PM577a in H1069Q-mutated Wilson Disease

Letter to Shareholders from Conn Davis, Chief Executive Officer: First 100 Days

RoboStrategy, Inc. Raises Approximately $28.9 Million Through Private Share Issuances

Terrestrial Energy and The Texas A&M University System Sign Agreements Advancing IMSR Commercial Deployment and R&D Projects at Texas A&M-RELLIS

FIS Sweeps All Three Chartis Enterprise Market Risk Quadrants in 2026

Denali Therapeutics Enters Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $195 Million

Hollister Teams Up with Target for Its First-Ever Home & Dorm Collaboration